Bharat Immunologicals & Biologicals Corporation Limited
BSE: BIBCL
Prev Close
23.18
Open Price
22.35
Volume
66,959
Today Low / High
22.32 / 24.19
52 WK Low / High
19 / 35.88
Range
22 - 25
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 23.49, reflecting a change of 0.31 (1.33736%). The expected target range on the BSE is 22 - 25. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Bharat Immunologicals & Biologicals Corporation Limited Graph
Bharat Immunologicals & Biologicals Corporation Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Bharat Immunologicals & Biologicals Corporation Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 23.49, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 23.49 | 23.72 | 21.35 - 26.10 |
| 23.96 | 19.17 - 28.75 | ||
| 24.19 | 16.94 - 31.45 | ||
| Bearish Scenario | 23.49 | 23.26 | 20.93 - 25.58 |
| 23.02 | 18.42 - 27.62 | ||
| 22.79 | 15.95 - 29.62 |
Overview of Bharat Immunologicals & Biologicals Corporation Limited
ISIN
INE994B01014
Industry
Medical - Pharmaceuticals
Vol.Avg
72,328
Market Cap
1,014,298,200
Last Dividend
0
Official Website
IPO Date
DCF Diff
39.79
DCF
-16
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 44.61 Cr | 59.28 Cr | -14.67 Cr | -0.3288 | 0.00 Cr | 0.64 Cr | -16.01 Cr | -16.64 Cr | -3.85 | -15.11 Cr | -0.3730 |
| 2022-03-31 | 78.39 Cr | 66.05 Cr | 12.34 Cr | 0.1574 | 0.00 Cr | 0.16 Cr | -4.86 Cr | -8.75 Cr | -2.03 | -3.88 Cr | -0.1117 |
| 2021-03-31 | 85.33 Cr | 88.35 Cr | -3.02 Cr | -0.0353 | 0.48 Cr | 0.13 Cr | -21.12 Cr | -18.11 Cr | -4.19 | -19.19 Cr | -0.2123 |
| 2020-03-31 | 66.84 Cr | 61.92 Cr | 4.92 Cr | 0.0735 | 0.52 Cr | 0.17 Cr | -10.60 Cr | -10.21 Cr | -2.36 | -9.22 Cr | -0.1528 |
| 2019-03-31 | 83.65 Cr | 79.69 Cr | 3.96 Cr | 0.0473 | 0.58 Cr | 0.13 Cr | -9.59 Cr | -5.79 Cr | -1.34 | -5.09 Cr | -0.0693 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 1.29 Cr | 188.65 Cr | 100.43 Cr | 88.2143 Cr | 70.22 Cr | 68.94 Cr | 1.42 Cr | 115.33 Cr | 0.00 Cr | 0.00 Cr | 9.28 Cr | 94.0424 Cr |
| 2022-03-31 | 4.64 Cr | 212.73 Cr | 107.38 Cr | 105.3531 Cr | 77.89 Cr | 73.24 Cr | 36.25 Cr | 115.98 Cr | 19.69 Cr | 0.00 Cr | 9.06 Cr | 101.2639 Cr |
| 2021-03-31 | 1.23 Cr | 103.99 Cr | 69.94 Cr | 34.0418 Cr | 27.29 Cr | 26.07 Cr | 13.49 Cr | 36.13 Cr | 2.88 Cr | 0.00 Cr | 12.52 Cr | 64.0907 Cr |
| 2020-03-31 | 0.99 Cr | 126.83 Cr | 106.36 Cr | 20.4738 Cr | 3.04 Cr | 2.05 Cr | 51.72 Cr | 4.68 Cr | 38.12 Cr | 0.00 Cr | 13.63 Cr | 100.7075 Cr |
| 2019-03-31 | 0.41 Cr | 124.96 Cr | 94.28 Cr | 30.6773 Cr | 32.22 Cr | 31.81 Cr | 14.44 Cr | 4.92 Cr | 0.05 Cr | 0.48 Cr | 9.50 Cr | 88.4754 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | 10.8924 Cr | 0.4622 Cr | -14.7118 Cr | 10.8924 Cr | -3.3571 Cr | 1.2859 Cr | 0.0000 Cr | -22.2679 Cr | -7.6669 Cr | 0.0000 Cr | 34.8276 Cr |
| 2022-03-31 | -42.1152 Cr | 0.5312 Cr | 45.0001 Cr | -42.1152 Cr | 3.4160 Cr | 4.6430 Cr | 0.0000 Cr | -9.6874 Cr | 50.5916 Cr | 0.0000 Cr | -22.7593 Cr |
| 2021-03-31 | 11.7769 Cr | 0.6688 Cr | -12.2030 Cr | 11.7764 Cr | 0.2420 Cr | 1.2270 Cr | -0.0005 Cr | -24.2078 Cr | -29.1839 Cr | 0.0000 Cr | 38.2284 Cr |
| 2020-03-31 | 34.0792 Cr | 0.9124 Cr | -34.4144 Cr | 34.0787 Cr | 0.5772 Cr | 0.9850 Cr | -0.0005 Cr | -14.2032 Cr | -29.1839 Cr | 0.0000 Cr | -37.2797 Cr |
| 2019-03-31 | -32.0958 Cr | 0.6982 Cr | 30.7074 Cr | -32.1209 Cr | -0.7899 Cr | 0.4078 Cr | -0.0251 Cr | -7.3735 Cr | 32.2223 Cr | 0.0000 Cr | -12.7176 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | 0.00 Cr | 0.03 Cr | -0.03 Cr | 0.0000 | -4.72 Cr | -4.92 Cr | -1.14 | -4.52 Cr | 0.0000 |
| 2023-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.0000 | -4.35 Cr | -4.59 Cr | -1.06 | -4.21 Cr | 0.0000 |
| 2023-03-31 | 7.65 Cr | 11.06 Cr | -3.41 Cr | -0.4463 | 4.30 Cr | -3.88 Cr | -0.99 | -3.61 Cr | -0.5066 |
| 2022-12-31 | 0.00 Cr | -1.32 Cr | 1.32 Cr | 0.0000 | -4.76 Cr | -4.68 Cr | -1.08 | -4.62 Cr | 0.0000 |
| 2022-09-30 | 26.48 Cr | 24.38 Cr | 2.10 Cr | 0.0793 | -2.54 Cr | -3.08 Cr | -0.71 | -2.18 Cr | -0.1164 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | 1.46 Cr | 7.45 Cr | 8.91 Cr | 10.03 Cr | 1.42 Cr | 32.71 Cr | 115.22 Cr | 188.13 Cr | 109.42 Cr |
| 2023-06-30 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-03-31 | 1.29 Cr | 7.45 Cr | 1.29 Cr | -7.45 Cr | 1.42 Cr | 35.80 Cr | 115.74 Cr | 188.65 Cr | 100.43 Cr |
| 2022-12-31 | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2022-09-30 | 0.18 Cr | 7.97 Cr | 8.14 Cr | 27.78 Cr | 8.23 Cr | 58.16 Cr | 115.91 Cr | 210.92 Cr | 113.64 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | -4.92 Cr | -4.92 Cr | 0.00 Cr | 0.00 Cr | -4.92 Cr | 1.46 Cr | 6.38 Cr | 0.00 Cr | -4.92 Cr |
| 2023-06-30 | -4.59 Cr | -4.59 Cr | 0.00 Cr | 0.00 Cr | -5.87 Cr | -4.59 Cr | 1.29 Cr | 0.00 Cr | -4.59 Cr |
| 2023-03-31 | -4.29 Cr | -4.29 Cr | 0.00 Cr | 0.00 Cr | -4.29 Cr | 1.29 Cr | 5.58 Cr | 0.00 Cr | -4.29 Cr |
| 2022-12-31 | -4.68 Cr | -4.68 Cr | 0.00 Cr | 0.00 Cr | -4.86 Cr | -4.68 Cr | 0.18 Cr | 0.00 Cr | -4.68 Cr |
| 2022-09-30 | -3.08 Cr | -3.08 Cr | 0.00 Cr | 0.00 Cr | -3.08 Cr | 0.18 Cr | 3.26 Cr | 0.00 Cr | -3.08 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹795.30 | ₹95,192,502,999.00 | ₹151,791.00 |
Key Executives
Gender: male
Year Born:
Gender: Not Specified
Year Born:
Gender: male
Year Born:
FAQs about Bharat Immunologicals & Biologicals Corporation Limited
The CEO is Dr. Dhananjay Kumar Tiwary.
The current price is ₹23.49.
The range is ₹19-35.88.
The market capitalization is ₹101.43 crores.
The P/E ratio is -6.10.
The company operates in the Healthcare sector.
Overview of Bharat Immunologicals & Biologicals Corporation Limited (ISIN: INE994B01014) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹101.43 crores and an average daily volume of 72,328 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.